Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy

A pilot study

Gregory T. Fossum, Kaylen M. Silverberg, Charles E. Miller, Michael Peter Diamond, Lena Holmdahl

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: To assess the safety and efficacy of Sepraspray Adhesion Barrier (a modified hyaluronic acid and carboxymethylcellulose powder) after laparoscopic surgery, in view of both the high efficacy of Seprafilm Adhesion Barrier in reducing postoperative adhesions after open surgical procedures and the difficulty with laparoscopic delivery. Design: Multicenter, randomized, reviewer-blinded trial. Setting: Reproductive endocrinology and infertility clinics. Patient(s): Women undergoing laparoscopic myomectomy for indications including infertility. Intervention(s): Randomization to treatment with (n = 21) or without (n = 20) Sepraspray Adhesion Barrier. Main Outcome Measure(s): Postoperative adhesions development was assessed at early second-look laparoscopy. Adhesions were scored using the modified American Fertility Society scoring system. Result(s): Surgical procedure duration length was 99 versus 102 minutes in the control versus Sepraspray Adhesion Barrier groups, respectively, with the median number of fibroids removed being two in each group and corresponding fibroid weights of 134 ± 103 versus 113 ± 161 g, respectively. Adhesions scores increased in both the control and Sepraspray Adhesion Barrier groups, with larger although nonstatistically significant increases noted in control subjects when evaluating for the anterior uterus, the posterior uterus, and the entire uterus. Conclusion(s): Laparoscopic application of Sepraspray Adhesion Barrier after myomectomy in this pilot study was associated with a trend toward a reduction in postoperative adhesion development, as well as an encouraging safety profile. Further evaluation is warranted.

Original languageEnglish (US)
Pages (from-to)487-491
Number of pages5
JournalFertility and Sterility
Volume96
Issue number2
DOIs
StatePublished - Aug 1 2011
Externally publishedYes

Fingerprint

Uterine Myomectomy
Uterus
Leiomyoma
Laparoscopy
Infertility
Safety
Carboxymethylcellulose Sodium
Endocrinology
Hyaluronic Acid
Random Allocation
Powders
Fertility
Outcome Assessment (Health Care)
Weights and Measures

Keywords

  • Adhesions
  • laparoscopy
  • myomectomy
  • Sepraspray Adhesion Barrier

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy : A pilot study. / Fossum, Gregory T.; Silverberg, Kaylen M.; Miller, Charles E.; Diamond, Michael Peter; Holmdahl, Lena.

In: Fertility and Sterility, Vol. 96, No. 2, 01.08.2011, p. 487-491.

Research output: Contribution to journalArticle

Fossum, Gregory T. ; Silverberg, Kaylen M. ; Miller, Charles E. ; Diamond, Michael Peter ; Holmdahl, Lena. / Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy : A pilot study. In: Fertility and Sterility. 2011 ; Vol. 96, No. 2. pp. 487-491.
@article{119fd76e2a3946b79d113c9028159a9f,
title = "Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: A pilot study",
abstract = "Objective: To assess the safety and efficacy of Sepraspray Adhesion Barrier (a modified hyaluronic acid and carboxymethylcellulose powder) after laparoscopic surgery, in view of both the high efficacy of Seprafilm Adhesion Barrier in reducing postoperative adhesions after open surgical procedures and the difficulty with laparoscopic delivery. Design: Multicenter, randomized, reviewer-blinded trial. Setting: Reproductive endocrinology and infertility clinics. Patient(s): Women undergoing laparoscopic myomectomy for indications including infertility. Intervention(s): Randomization to treatment with (n = 21) or without (n = 20) Sepraspray Adhesion Barrier. Main Outcome Measure(s): Postoperative adhesions development was assessed at early second-look laparoscopy. Adhesions were scored using the modified American Fertility Society scoring system. Result(s): Surgical procedure duration length was 99 versus 102 minutes in the control versus Sepraspray Adhesion Barrier groups, respectively, with the median number of fibroids removed being two in each group and corresponding fibroid weights of 134 ± 103 versus 113 ± 161 g, respectively. Adhesions scores increased in both the control and Sepraspray Adhesion Barrier groups, with larger although nonstatistically significant increases noted in control subjects when evaluating for the anterior uterus, the posterior uterus, and the entire uterus. Conclusion(s): Laparoscopic application of Sepraspray Adhesion Barrier after myomectomy in this pilot study was associated with a trend toward a reduction in postoperative adhesion development, as well as an encouraging safety profile. Further evaluation is warranted.",
keywords = "Adhesions, laparoscopy, myomectomy, Sepraspray Adhesion Barrier",
author = "Fossum, {Gregory T.} and Silverberg, {Kaylen M.} and Miller, {Charles E.} and Diamond, {Michael Peter} and Lena Holmdahl",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.fertnstert.2011.05.081",
language = "English (US)",
volume = "96",
pages = "487--491",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy

T2 - A pilot study

AU - Fossum, Gregory T.

AU - Silverberg, Kaylen M.

AU - Miller, Charles E.

AU - Diamond, Michael Peter

AU - Holmdahl, Lena

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objective: To assess the safety and efficacy of Sepraspray Adhesion Barrier (a modified hyaluronic acid and carboxymethylcellulose powder) after laparoscopic surgery, in view of both the high efficacy of Seprafilm Adhesion Barrier in reducing postoperative adhesions after open surgical procedures and the difficulty with laparoscopic delivery. Design: Multicenter, randomized, reviewer-blinded trial. Setting: Reproductive endocrinology and infertility clinics. Patient(s): Women undergoing laparoscopic myomectomy for indications including infertility. Intervention(s): Randomization to treatment with (n = 21) or without (n = 20) Sepraspray Adhesion Barrier. Main Outcome Measure(s): Postoperative adhesions development was assessed at early second-look laparoscopy. Adhesions were scored using the modified American Fertility Society scoring system. Result(s): Surgical procedure duration length was 99 versus 102 minutes in the control versus Sepraspray Adhesion Barrier groups, respectively, with the median number of fibroids removed being two in each group and corresponding fibroid weights of 134 ± 103 versus 113 ± 161 g, respectively. Adhesions scores increased in both the control and Sepraspray Adhesion Barrier groups, with larger although nonstatistically significant increases noted in control subjects when evaluating for the anterior uterus, the posterior uterus, and the entire uterus. Conclusion(s): Laparoscopic application of Sepraspray Adhesion Barrier after myomectomy in this pilot study was associated with a trend toward a reduction in postoperative adhesion development, as well as an encouraging safety profile. Further evaluation is warranted.

AB - Objective: To assess the safety and efficacy of Sepraspray Adhesion Barrier (a modified hyaluronic acid and carboxymethylcellulose powder) after laparoscopic surgery, in view of both the high efficacy of Seprafilm Adhesion Barrier in reducing postoperative adhesions after open surgical procedures and the difficulty with laparoscopic delivery. Design: Multicenter, randomized, reviewer-blinded trial. Setting: Reproductive endocrinology and infertility clinics. Patient(s): Women undergoing laparoscopic myomectomy for indications including infertility. Intervention(s): Randomization to treatment with (n = 21) or without (n = 20) Sepraspray Adhesion Barrier. Main Outcome Measure(s): Postoperative adhesions development was assessed at early second-look laparoscopy. Adhesions were scored using the modified American Fertility Society scoring system. Result(s): Surgical procedure duration length was 99 versus 102 minutes in the control versus Sepraspray Adhesion Barrier groups, respectively, with the median number of fibroids removed being two in each group and corresponding fibroid weights of 134 ± 103 versus 113 ± 161 g, respectively. Adhesions scores increased in both the control and Sepraspray Adhesion Barrier groups, with larger although nonstatistically significant increases noted in control subjects when evaluating for the anterior uterus, the posterior uterus, and the entire uterus. Conclusion(s): Laparoscopic application of Sepraspray Adhesion Barrier after myomectomy in this pilot study was associated with a trend toward a reduction in postoperative adhesion development, as well as an encouraging safety profile. Further evaluation is warranted.

KW - Adhesions

KW - laparoscopy

KW - myomectomy

KW - Sepraspray Adhesion Barrier

UR - http://www.scopus.com/inward/record.url?scp=79960633749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960633749&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2011.05.081

DO - 10.1016/j.fertnstert.2011.05.081

M3 - Article

VL - 96

SP - 487

EP - 491

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -